Pipeline

AZAD continually invests into further development and expansion of its API portfolios. Process research on new APIs is performed under the supervision of AZAD’s chemists based in Switzerland, at our R&D labs in Armenia, allowing cost-effective development of innovative chemistry and polymorphic forms of APIs, that are then patent-protected. In addition, using the above facility and expertise, AZAD offers contract R&D for 3rd parties interested in synthetic route development of specific APIs.

Active Pharmaceutical Ingredients

Product Indication Remark
Bilastine Antihistamine
Ferric Carboxymaltose Iron deficiency Produced in Switzerland
Nelarabine Leukemia
Tafamidis ATTR-Amyloidose (CM and PN) New polymorph; produced in Switzerland